MRKR
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Marker Therapeutics announces first patient treated in off-the-shelf programOct 6, 2025
- Marker Therapeutics provides update on Phase 1 APOLLO study highlighting encouraging overall response rates in relapsed lymphomaAug 26, 2025
- Marker Therapeutics to highlight multi-antigen recognizing (MAR)-T cells in a high-profile panel on CAR-T cell therapies.May 19, 2025